Decrease in vRNA in brain during antiretroviral therapy. by Sonny R. Elizaldi (9684796)

Percent Decrease in FGM between Oldest (45-49 years) and Youngest (15-19 years) Cohorts of Women over the years in Egypt. by Shatha Elnakib (8901764)

Data_Sheet_1_Immune and Neuroendocrine Trait and State Markers in Psychotic Illness: Decreased Kynurenines Marking Psychotic Exacerbations.docx by Livia De Picker (8319105)

“…</p><p>Results: Patients had significantly higher plasma concentrations of CRP, CCL2, IL1RA, and lower concentrations of KA and KA/Kyn at all time points (F7.5–17.5, all p < 0.001). …”

VOC Alpha spike protein shows decreased proteolytic processing. by Daniela Niemeyer (199082)

Significant condition. by Junxia Zhou (14381598)

FASN Expression in OA and RA–shows that FASN is also significantly downregulated in the disease groups for OA and RA, suggesting its decreased activity might influence disease mech... by Chang-sheng Liao (18591969)

Non-metric Multidimensional Scaling (NMDS) plot showing significant correlations (<i>P</i> < 0.05) between microbiota and clinical variables in the Staph group. by Paulo Kussek (13410476)

Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index. by Søren Egstrand (10906087)

List of the proteins that increased or decreased significantly with the progression of liver fibrosis. by Kumiko Shirai (13014884)

Subjects:

List of 1483 genes that were significantly (<i>P</i> < 0.1) increased or decreased in any galactose-treated sample. by Masaya Nagaya (13851123)

Significance level (<i>p</i>−values) of the post hoc pairwise multiple comparisons between the different experimental conditions for the parameters showing significant dependence o... by Frédéric Dierick (4063213)

Significantly Enriched Pathways. by Jiyong Zhang (2498740)

Subjects:

The iTRAQ-based proteomics, and the histopathologic and immunohistologic assessments of skin tissues obtained from patients with SSc. by Jing Mao (148640)

Subjects:

The hypoxia-induced changes of HIF-1α, VEGF-a, VEGFR1 and VEGFR2 at the mRNA and protein level. by Jing Mao (148640)

Subjects:

The primers for PCR analyses. by Jing Mao (148640)

Subjects:

Clinical and demographic characteristics of SSc patients and controls. by Jing Mao (148640)

Subjects:

The iTRAQ-based proteomics data. by Jing Mao (148640)

Subjects:

The hypoxia-treated ECs were incubated with tamoxifen, the HIF-1α inhibitor, and the expression of CD31, α-SMA and fibronectin were detected. by Jing Mao (148640)

Subjects:

The hypoxia-induced changes of endothelial and fibrotic markers. by Jing Mao (148640)

Subjects:

The hypoxia-treated ECs were incubated with bevacizumab, the VEGF-a inhibitor, and the expression of VEGF-a, HIF-1α, CD31 and α-SMA were detected. by Jing Mao (148640)

Subjects: